<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xmlns:video="http://www.google.com/schemas/sitemap-video/1.1"
        xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://global.investnews.co.kr/news/konex-market-report-september-2026</loc>
    <lastmod>2026-10-14T12:05:38+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/konex-market-report-september-2026"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/konex-market-report-september-2026"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/konex-market-report-september-2026"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/konex-market-report-september-2026"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/konex-market-report-september-2026"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T12:05:38+09:00</news:publication_date>
      <news:title><![CDATA[[September 2026 KONEX Monthly Market Report] Trading Value Decreases by 39%... New Listings Follow as Transfer Listings Face Obstacles]]></news:title>
      <news:keywords><![CDATA[KONEX, Korea Exchange, Bon Systems, SK Signet, Ensol Bioscience, PharmaResearch Bio, Jincostech]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/00ddafa8-5bd1-4bfb-b5f4-17faf791c4f4-8765fbb7-og16x9.webp</image:loc>
      <image:caption><![CDATA[In September, the KONEX market showed mixed results with an increase in trading volume but a 39.4% decrease in trading value. While the first case of transfer listing to KONEX for companies facing delisting was delayed due to court decisions, new listing applications continue.]]></image:caption>
      <image:title><![CDATA[[September 2026 KONEX Monthly Market Report] Trading Value Decreases by 39%... New Listings Follow as Transfer Listings Face Obstacles]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://global.investnews.co.kr/news/s-innovations-amr-pre-a-investment</loc>
    <lastmod>2026-10-14T11:02:01+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/s-innovations-amr-pre-a-investment"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/s-innovations-amr-pre-a-investment"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/s-innovations-amr-pre-a-investment"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/s-innovations-amr-pre-a-investment"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/s-innovations-amr-pre-a-investment"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-14T11:02:01+09:00</news:publication_date>
      <news:title><![CDATA[[Series] S Innovations, an AMR operation automation company, attracts 3 billion won in Pre-A investment to advance technology]]></news:title>
      <news:keywords><![CDATA[S Innovations, AMR, SynK, Quantum Ventures Korea, Korea Credit Guarantee Fund, Daekyo Investment, autonomous mobile robot]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/5731c1d0-0893-4fa7-83f5-086a1e6f5457-54ca211e-og16x9.webp</image:loc>
      <image:caption><![CDATA[S Innovations, an autonomous mobile robot (AMR) operation automation platform company, has secured 3 billion won in Pre-A funding. The investment, which includes participation from Quantum Ventures Korea, Korea Credit Guarantee Fund, and Daekyo Investment, brings the company's cumulative investment to 4.4 billion won.]]></image:caption>
      <image:title><![CDATA[[Series] S Innovations, an AMR operation automation company, attracts 3 billion won in Pre-A investment to advance technology]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://global.investnews.co.kr/news/ms-bio-ipo-kosdaq-subscription-success</loc>
    <lastmod>2026-10-13T19:12:07+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/ms-bio-ipo-kosdaq-subscription-success"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/ms-bio-ipo-kosdaq-subscription-success"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/ms-bio-ipo-kosdaq-subscription-success"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/ms-bio-ipo-kosdaq-subscription-success"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/ms-bio-ipo-kosdaq-subscription-success"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-13T19:12:07+09:00</news:publication_date>
      <news:title><![CDATA[[IPO] MS Bio's competitiveness as a 'profitable bio company' pays off... Subscription ratio of 1538:1]]></news:title>
      <news:keywords><![CDATA[MS Bio, KOSDAQ Market, IPO, KB Securities, medical devices, human tissue]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/e181cd7a-d36e-4d86-bbf1-7a8148cf6230-47fe42ed-og16x9.webp</image:loc>
      <image:caption><![CDATA[MS Bio successfully completed its public subscription for its upcoming KOSDAQ listing on the 22nd, driven by expectations for the medical device market and the company's profitability.]]></image:caption>
      <image:title><![CDATA[[IPO] MS Bio's competitiveness as a 'profitable bio company' pays off... Subscription ratio of 1538:1]]></image:title>
    </image:image>
  </url>
</urlset>
